Live Analyst Rating Changes 10175 upgrades, downgrades & price-target moves · freshest Wall Street data, updated daily View live feed →
Analyst Tracker/Puneet Souda
LP
Puneet Souda
Leerink Partners
Wall Street Analyst
★★★★☆
#607
on 13Foresight · ranked by our own returns
76%
Success Rate
+33.2%
Average Return
26 of 34 calls profitable · +20.5% vs benchmark
S&P 500 (SPY)
📈 Across the calls we could measure, roughly 76% of Puneet Souda's ratings turned a profit when each position was held for 1 year — averaging +33.2% per rating. These figures are computed by 13Foresight from historical prices, not supplied by the analyst.

Rating Distribution

43 Buy 16 Hold 0 Sell
Puneet's Stock Coverage 32 ratings · 2026-07-20
Company Date Position Consensus ⓘ Price Target ⓘ 1-Yr Return
TXG
10x Genomics
 Jul 17, 2026 HOLD Buy
-22.6% avg upside
18 analysts
$40.00
8.51% Downside
 ·
TWST
Twist Bioscience
 Jul 17, 2026 BUY Strong Buy
-14.2% avg upside
14 analysts
$110.00
17.27% Upside
 +0.0%
ILMN
Illumina
 Jul 17, 2026 BUY Buy
-13.6% avg upside
30 analysts
$210.00
12.45% Upside
 +0.0%
TECH
Bio-Techne
 Jun 25, 2026 HOLD Hold
+15.7% avg upside
21 analysts
$73.00
1.29% Upside
 +1.1%
NTRA
Natera
 Jun 22, 2026 BUY Strong Buy
-2.5% avg upside
26 analysts
 — +18.6%
GH
Guardant Health
 Jun 02, 2026 BUY Strong Buy
-5.1% avg upside
31 analysts
 — +19.7%
ALMR
Alamar Biosciences, Inc.
 May 12, 2026 BUY Strong Buy
+18.7% avg upside
5 analysts
$35.00
34.81% Upside
 +8.6%
NEO
NeoGenomics
 Apr 29, 2026 BUY Strong Buy
+10.8% avg upside
17 analysts
$25.00
71.19% Upside
 +65.6%
TMO
Thermo Fisher
 Oct 23, 2025 BUY Strong Buy
+10.4% avg upside
38 analysts
$580.00
8.89% Upside
 -6.6%
DHR
Danaher
 Oct 22, 2025 BUY Strong Buy
+6.0% avg upside
45 analysts
$235.00
15.29% Upside
 -6.0%
RVTY
Revvity
 Sep 16, 2025 BUY Buy
-3.2% avg upside
23 analysts
$110.00
0.21% Downside
 +29.5%
RGEN
Repligen
 Sep 11, 2025 BUY Strong Buy
+16.4% avg upside
25 analysts
$200.00
35.86% Upside
 +24.3%
QTRX
Quanterix
 Sep 10, 2025 HOLD Buy
+391.6% avg upside
8 analysts
$6.00
55.19% Upside
 -7.4%
BRKR
Bruker
 Sep 07, 2025 BUY Strong Buy
-2.1% avg upside
22 analysts
 — +93.3%
A
Agilent
 Sep 01, 2025 BUY Strong Buy
+12.9% avg upside
33 analysts
$140.00
6.54% Upside
 +6.7%
OABI
OmniAb
 Aug 07, 2025 BUY Strong Buy
+266.9% avg upside
10 analysts
$10.00
371.66% Upside
 +8.5%
VCYT
Veracyte
 Aug 07, 2025 BUY Hold
-15.6% avg upside
18 analysts
$45.00
23.89% Downside
 +113.9%
MASS
908 Devices
 Aug 06, 2025 BUY Strong Buy
+49.6% avg upside
4 analysts
$12.00
63.21% Upside
 +12.5%
CYRX
CryoPort
 Aug 06, 2025 BUY Strong Buy
-13.1% avg upside
15 analysts
$16.00
3.01% Downside
 +88.7%
MYGN
Myriad Genetics
 Aug 06, 2025 HOLD Hold
+192.7% avg upside
24 analysts
$9.00
45.69% Upside
 +6.5%
CSTL
Castle Biosciences
 Aug 05, 2025 BUY Strong Buy
+71.6% avg upside
9 analysts
$35.00
44.90% Upside
 +13.6%
WAT
Waters
 Aug 05, 2025 BUY Buy
+2.9% avg upside
30 analysts
$340.00
7.77% Downside
 +31.2%
LINK
Interlink Electronics
 Jul 29, 2025 BUY Strong Buy
+115.0% avg upside
16 analysts
 — +4.3%
HHS
Harte-Hanks
 Jun 01, 2025 BUY Strong Buy
2 analysts
 — -42.4%
ABCL
AbCellera Biologics
 May 09, 2025 BUY Buy
+108.2% avg upside
15 analysts
$5.00
22.73% Downside
 +158.1%
SNDA
Sonida Senior Living
 May 07, 2024 BUY Buy
+120.7% avg upside
12 analysts
 — -26.6%
AB
AllianceBernstein
 Dec 19, 2023 BUY Hold
-3.6% avg upside
8 analysts
 — +18.3%
SVRN
OceanPal Inc
 Jun 13, 2023 HOLD Strong Buy
6 analysts
 — ·
DMRA
Damora Therapeutics
 Apr 29, 2022 BUY Strong Buy
-13.4% avg upside
19 analysts
$16.00
49.23% Downside
 +4.8%
TTOO
T2 Biosystems
 Aug 24, 2021 BUY Buy
+1015078.6% avg upside
10 analysts
$3.00
428471.49% Upside
 ·
HTGMQ
HTG Molecular Diagnostics
 Aug 24, 2021 BUY Strong Buy
+733333233.2% avg upside
6 analysts
$10.00
999999899.91% Upside
 ·
BAX
Baxter International
 Oct 20, 2014 BUY Buy
+33.2% avg upside
23 analysts
$80.00
253.78% Upside
 -4.7%
🔒 27 more ratings — with price targets, crowd consensus and our measured returns.
Sign in free to unlock See Pro plans
Free account unlocks every analyst's full coverage table.
Puneet Souda — Frequently Asked Questions
How accurate are Puneet Souda's stock ratings?
Based on the calls 13Foresight could measure, about 76% of Puneet's ratings were profitable over a one-year hold, with an average return of +33.2% per rating, or +20.8% versus the S&P 500. We score every analyst the same way, from historical prices. Each return is measured in the stock's own trading currency, so for non-US listings the S&P 500 comparison leaves out currency moves.
How is Puneet ranked on 13Foresight?
Puneet Souda is currently ranked #607 with a 4-star rating. Our rank blends hit rate, average return versus the market, and how many calls we have to judge — so a long, consistent record outweighs a few lucky picks. It is our own calculation, updated daily.
Which stocks does Puneet cover?
Puneet most recently has ratings on TXG, TWST, ILMN, TECH, NTRA, GH, ALMR, NEO, TMO, DHR, RVTY, RGEN and 20 more. See the full coverage table above for positions, price targets and our measured returns.
Where can I see other analyst ratings?
Browse the full analyst leaderboard to compare Wall Street analysts ranked by their measured performance, success rate and average return.

Disclaimer: 13Foresight compiles analyst ratings and price targets from publicly available sources. Performance metrics, rankings and star ratings shown here are calculated independently by 13Foresight from historical market prices and may differ from figures published elsewhere. This information may be incomplete, delayed or inaccurate, is provided for research and informational purposes only, and is not investment advice. The underlying ratings and opinions are those of the respective analysts and their firms; 13Foresight accepts no liability for any decisions made based on this data.